The seven EMREE subject banks
| Discipline | Official weight | Approx. questions* | Outline focus |
|---|---|---|---|
| Internal Medicine | 20% | 24 | All major systems, acute care, oncology, geriatrics |
| Obstetrics and Gynaecology | 15% | 18 | Pregnancy, labour, gynaecology, oncology, family planning |
| Paediatrics | 15% | 18 | General, ambulatory, neonatal, endocrine, metabolic |
| Surgery | 15% | 18 | Principles, general surgery, trauma, subspecialties |
| Family Medicine | 15% | 18 | Ethics and Patient Safety |
| Psychiatry | 10% | 12 | Mood, anxiety, risk, substance, ADHD |
| Public Health / Preventive Medicine | 10% | 12 | Biostatistics, screening, prevention, outbreaks |
*Question counts are our arithmetic (weight × 120). The blueprint publishes percentages only, with a ±5% tolerance per category.
A 72-year-old woman presents with two weeks of intermittent palpitations. She has hypertension and type 2 diabetes mellitus and no history of bleeding, falls or liver disease. Her pulse is irregularly irregular at 88/min and blood pressure is 136/82 mmHg. ECG confirms atrial fibrillation with no other abnormality. Echocardiography shows a structurally normal heart with no mitral stenosis, and eGFR is 68 mL/min/1.73 m².
Which of the following is the most appropriate long-term antithrombotic therapy?
Show answer & explanation
Correct answer: C.
Her CHA2DS2-VASc score is 4 (age 65–74, female sex, hypertension, diabetes); even with the sex-neutral CHA2DS2-VA score used by ESC 2024 it is 3, well above the threshold for oral anticoagulation. In non-valvular AF without moderate-to-severe mitral stenosis or a mechanical valve, a DOAC is preferred over warfarin because it has lower rates of intracranial haemorrhage and needs no INR monitoring. Antiplatelet agents should not be used for stroke prevention in AF. Bleeding risk should be assessed (e.g. ORBIT or HAS-BLED) to modify risk factors, not to withhold anticoagulation.
- A: Antiplatelet monotherapy is not recommended for stroke prevention in AF: it is much less effective than anticoagulation and carries a similar bleeding risk.
- B: Dual antiplatelet therapy is inferior to oral anticoagulation for AF stroke prevention and causes significant bleeding.
- D: Her stroke risk is already high (CHA2DS2-VASc 4), so withholding anticoagulation is not appropriate.
High-yield: CHA2DS2-VASc ≥2 in men or ≥3 in women (CHA2DS2-VA ≥2) – offer oral anticoagulation. · DOACs are first-line in non-valvular AF; warfarin is required for mechanical valves and moderate–severe mitral stenosis. · Aspirin has no role as sole stroke prevention in AF.
Original practice question written by EMREE UAE — not a past EMREE question.
What makes our questions EMREE-relevant
- Blueprint-mapped: every item is tagged to an official outline heading, so you can see coverage topic by topic.
- Clinically pitched: the official exam structure page targets the knowledge of “a graduate with at least one year training”, testing clinical application, diagnosis and management in a UAE context. Our vignettes follow that brief.
- Official format cues: four-option single-best-answer, matching the official 2012 sample paper. The current number of options is not officially stated.
- Competency-tagged: using the blueprint’s seven physician competencies, from Fundamental Scientific Concepts to Professionalism, Ethics & Communication.
- Difficulty-balanced: close to the official 40% easy, 40% moderate and 20% difficult split.
Our questions are not real or recalled EMREE questions, and we never claim they are.
Inside every explanation
- Why the correct answer is right, with the key clinical reasoning.
- A one-line reason why each distractor is wrong.
- Two or three high-yield learning points to add to your notes.
- References to standard texts or current clinical guidelines, such as NICE, ACOG or the textbooks on the official reading list.
Ways to practise
- Tutor mode: see the explanation after each answer. Best for learning a new topic.
- Timed mode: answer against the clock at about 1.5 minutes per question, the average pace of 120 questions in 3 hours. See timed practice tests.
- Subject tests: focused sets for one discipline. See subject-specific tests.
- Custom tests: pick subjects, outline headings, difficulty and question count in the custom exam builder.
- Full-length mocks: 120 questions in 3 hours, weighted to the blueprint. See full-length mock exams.
Tracking your progress
Practice is only useful if you learn from it. Depending on your plan, your dashboard shows:
- Basic progress (Starter and above): questions attempted and percentage correct by subject.
- Bookmarks and weak-area practice (Standard and above): save difficult items and generate sets from topics where you score lowest.
- Advanced analytics (Premium): deeper breakdowns, for example by blueprint heading, competency and difficulty, so you can see whether you lose marks on diagnosis, drug therapy or ethics questions.
Practice scores are a guide to your progress, not a prediction of your EMREE result. The real exam’s pass mark is set by the board each cycle (60% for 2025-26); see EMREE passing score.
Free and paid access
You can try sample MCQs and the free 20-question diagnostic test without paying. Paid plans start with Starter at AED 99 for 30 days, which unlocks all seven subject banks, tutor and timed modes and full explanations. Standard (AED 199 for 90 days) adds full-length mocks, custom tests, bookmarks, weak-area practice and study plans, and Premium (AED 299 for 180 days) adds advanced analytics, extended practice sets and priority support. VAT is applied at checkout where applicable. Compare on the pricing page.
Suggested order of study (our recommendation)
- Take the free diagnostic to find your weakest disciplines.
- Start with Internal Medicine (20%), then the four 15% subjects.
- Schedule Family Medicine (Ethics and Patient Safety) early; it is often under-prepared.
- Do not leave Psychiatry and Public Health to the end; together they are worth about as much as Internal Medicine.
- Finish with mixed timed sets and full-length mocks.
For the full topic list, see the EMREE syllabus. No question bank can guarantee a pass, but steady, blueprint-weighted practice is a sound approach.
Frequently asked questions
Are these real EMREE exam questions?
No. They are original practice questions written for preparation and mapped to the official blueprint.
How many options does each question have?
Four, matching the official 2012 sample paper. The current exam's number of options is not officially stated.
Can I try questions for free?
Yes. Sample MCQs and the 20-question diagnostic are free.
Are the questions weighted like the real exam?
Our full-length mocks follow the published blueprint percentages and the 40/40/20 difficulty split. Per-discipline counts are our simulation of those percentages.
Which plan includes all seven subjects?
All paid plans, starting with Starter at AED 99 for 30 days.
Sources
Official information last verified on . Rules and dates can change — always confirm on the official site before you register or apply.